Hybrid MXene/Hydrogel Integration with Modulated Bioactivities for Synergistic Diabetic Wound Therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42024460.
- Also identified by DOI 10.1021/acs.nanolett.6c00565.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Effective management of diabetic wounds requires the simultaneous modulation of bacterial infection, oxidative stress, and angiogenesis. Here, we present a dynamic, self-healing hydrogel platform that integrates Ti<sub>3</sub>C<sub>2</sub> MXene nanosheets and epidermal growth factor (EGF) within a glutathione-modified chitosan/alginate network. This injectable system uses dynamic Schiff-base cross-linking to provide superior tissue adhesion and conformability. Under near-infrared (NIR) irradiation, the single-layer MXene nanosheets enable robust photothermal antibacterial activity and trigger on-demand EGF release, which stimulates neovascularization. Simultaneously, the glutathione moieties actively scavenge reactive oxygen species (ROS). In vivo assessments in a diabetic wound model revealed accelerated wound closure (96%), reduced inflammation, and a restored tissue architecture. Our study highlights a triple-synergistic strategy combining photothermal therapy, antioxidant protection, and angiogenic promotion, demonstrating the potential of rationally engineered MXene-based hydrogels for treating inflammation-associated pathologies.
Medical subject headings
- Hydrogels
- Wound Healing
- Anti-Bacterial Agents
- Diabetes Mellitus, Experimental
- Nanostructures